CCN2 and pulmonary fibrosis: Interestingly, low dose CTGF treatment in LPS-induced acute lung injury in mice alleviated alveolar damage, whereas high dosing of CTGF resulted in pulmonary fibrosis (Sun et al. 2023), suggesting dose-dependent effects of CTGF.